Alembic Pharmaceuticals has received final approval from the USFDA for its generic Carbamazepine extended-release tablets, used for treating seizures and nerve pain. The approval covers 100 mg, 200 mg ...

Eli Lilly & Company (NYSE: LLY) ranks among the best non-tech stocks to buy according to billionaires. Eli Lilly & Company ...

Shares in nuclear medicine play Clarity Pharmaceuticals have surged up to 12% after the company's swift $203 million raising.

The latest health updates include Centene's improved profitability forecast, US-initiated healthcare data-sharing plans ...

Over the past decade, health insurance companies have increasingly embraced the use of artificial intelligence algorithms – ...

Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure ...

From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.

Most Americans encounter the Federal Trade Commission only if they’ve been scammed: It handles identity theft, fraud, and ...

Xuewu Liu, a Chinese inventor who has no medical training or credentials of any kind, is charging cancer patients $20,000 for ...

Stoned AI delivers hallucinations and headaches The Trump administration is flogging artificial intelligence as the silver ...

Corcept Therapeutics Incorporated (NASDAQ: CORT) is one of the growth stocks that could double by 2027. On July 14, CORT ...

In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...